These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7181477)

  • 1. Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):672-7. PubMed ID: 7181477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.
    Brumfitt W; Hamilton-Miller JM
    Antimicrob Agents Chemother; 1984 Feb; 25(2):276-8. PubMed ID: 6561953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin-clavulanate (Clavulin). Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Infectious Diseases and Immunization Committee
    CMAJ; 1985 Oct; 133(8):739. PubMed ID: 4042055
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.
    Leigh A
    Scott Med J; 1982; 27 Spec No.():S28-34. PubMed ID: 6984778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1986 Jan; 29(1):107-11. PubMed ID: 3524418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
    Nakazawa H; Hashimoto T; Nishiura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Sep; 24(3):437-9. PubMed ID: 6357078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin/clavulanate in urinary tract infection.
    Gasser TC; Larsen EH; Madsen PO
    Urology; 1987 Jan; 29(1):111-4. PubMed ID: 3541346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ; Tolkoff-Rubin NE; Rubin RH
    Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of urinary infection with a combination of amoxycillin and clavulanic acid].
    Vránková J; Kocvara R
    Cas Lek Cesk; 1983 Sep; 122(37):1144-5. PubMed ID: 6627336
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of bacterial adhesins in the outcome of childhood urinary tract infections.
    Johnson CE; Maslow JN; Fattlar DC; Adams KS; Arbeit RD
    Am J Dis Child; 1993 Oct; 147(10):1090-3. PubMed ID: 8105678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
    Fancourt GJ; Matts SG; Mitchell CJ
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

  • 16. Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice.
    Cooper J; Raeburn A; Brumfitt W; Hamilton-Miller JM
    Infection; 1990; 18(2):65-9. PubMed ID: 2185155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
    Cohen Stuart J; Leverstein-Van Hall M; Kortmann W; Verlind J; Mulder F; Scharringa J; Fluit A; Ekkelenkamp M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):2021-2025. PubMed ID: 30117050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.
    Brumfitt W; Hamilton-Miller JM
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1803-5. PubMed ID: 2285294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
    Tehan S; Lamb YJ
    J Antimicrob Chemother; 1990 Jul; 26(1):151-2. PubMed ID: 2211437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.